You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oxaliplatin, fluorouracil, and leucovorin

Showing 1 - 25 of 3,148
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin

Recruiting
  • Hepatocellular Carcinoma
  • Raltitrexed, oxaliplatin (SALOX) treatment
  • Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 17, 2022

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022

Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Frankfurt, Germany
  • +1 more
Oct 3, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Hepatocellular Carcinoma Trial in Wuhan (HAIC, Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Hepatocellular Carcinoma
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Nov 8, 2022

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)

Not yet recruiting
  • Neuropathy;Peripheral
  • Placebo tablets
  • Ketotifen Oral Tablet
  • Tanta, Egypt
    Tanta university
Nov 23, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • GastroEsophageal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2022

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +5 more
  • Biospecimen Collection
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2023

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Malignant Digestive System Tumor Trial in Atlanta (Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Malignant Digestive System Neoplasm
  • Atlanta, Georgia
  • +2 more
Dec 12, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022

Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFOX regimen
  • +7 more
  • New Brunswick, New Jersey
  • +1 more
Jul 1, 2022

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

Active, not recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022

Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • JS015
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 17, 2023